← Leaderboards
Laurie A Whittaker
University Of Vermont &St Agric College
$1,689,359
Attributed
$1,689,359
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $341.1K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,689,359 · 7
By mechanism
P20$1,664,440 · 5
M01$24,919 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Vermont &St Agric College
Same institution · by research overlap
- Cynthia K Sites$1,338,168
- Ralph C. Budd$28,686,640
Research focus
Computer Retrieval Of Information On Scientific Projects DatabaseResourcesUnited States National Institutes Of HealthCystic Fibrosis PatientsFundingCystic FibrosisGrantSourceResearch PersonnelInstitutionProductionDefectLungLymphocyteAsthmaCystic Fibrosis Transmembrane Conductance RegulatorLearningImmune SystemCystic Fibrosis AirwayAffectCd4 Positive T LymphocytesCystic Fibrosis MouseAntigensFuture
Grant awards (10)
CD4 T CELLS: LESSONS LEARNED FROM ASTHMA$299,763
P20 · FY2009 · RR · contact PI
CD4 T CELLS: LESSONS LEARNED FROM ASTHMA$283,090
P20 · FY2008 · RR · contact PI
CD4 T CELLS: LESSONS LEARNED FROM ASTHMA$276,933
P20 · FY2007 · RR · contact PI
DIABETES THER TO IMPROVE BMI & PULMONARY FUNCTION IN CF WITH ABN GLUCOSE TOL$6,869
M01 · FY2007 · RR · contact PI
CD4 T CELLS: LESSONS LEARNED FROM ASTHMA$331,022
P20 · FY2006 · RR · contact PI
DIABETES THER TO IMPROVE BMI & PULM FUNCT IN CF SUBJ WITH ABNORMAL GLUC TOL$10,107
M01 · FY2006 · RR · contact PI
COBRE: UVT: TH2 MEDIATED AIRWAY INFLAMMATION IN MOUSE$215,786
P20 · FY2005 · RR
DIABETES THERAPY TO IMPROVE BMI AMP;PULM FUNCT IN CF SUBJ W/ ABNORMAL GLUC TOL$6,469
M01 · FY2005 · RR
COBRE: UVT: TH2 MEDIATED AIRWAY INFLAMMATION IN THE DELTAF508 MOUSE$257,846
P20 · FY2004 · RR
Diabetes Ther. to Improve BMI &Pulm. Funct. in CF Subj. with Abnormal Gluc Tol$1,474
M01 · FY2004 · RR